Saliha Moutaharrik

Dr. Saliha Moutaharrik

Università degli Studi di Milano
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
Alice MelocchiAlice Melocchi
Alice Melocchi
MUMarco Uboldi
Marco Uboldi
MCMatteo Cerea
Matteo Cerea
AFAnastasia Foppoli
Anastasia Foppoli
AMAlessandra Maroni
Alessandra Maroni
AGAndrea Gazzaniga
Andrea Gazzaniga

1 October 2020 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
AMAlice Melocchi
Alice Melocchi
MUMarco Uboldi
Marco Uboldi
MCMatteo Cerea
Matteo Cerea
AFAnastasia Foppoli
Anastasia Foppoli
AMAlessandra Maroni
Alessandra Maroni
AGAndrea Gazzaniga
Andrea Gazzaniga

8 December 2016 in Expert Opinion on Drug Delivery
Verified
Journal Article
Open access
AMAlessandra Maroni
Alessandra Maroni
Saliha MoutaharrikSaliha Moutaharrik
Saliha Moutaharrik
LZLucia Zema
Lucia Zema
Andrea GazzanigaAndrea Gazzaniga
Andrea Gazzaniga
(2017). Enteric coatings for colonic drug delivery: state of the art. Expert Opinion on Drug Delivery: Vol. 14, No. 9, pp. 1027-1029.

1 December 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
AFAnastasia Foppoli
Anastasia Foppoli
AMAlessandra Maroni
Alessandra Maroni
Saliha MoutaharrikSaliha Moutaharrik
Saliha Moutaharrik
Alice MelocchiAlice Melocchi
Alice Melocchi
LZLucia Zema
Lucia Zema
AGAndrea Gazzaniga
Andrea Gazzaniga

9 December 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Andrea GazzanigaAndrea Gazzaniga
Andrea Gazzaniga
Saliha MoutaharrikSaliha Moutaharrik
Saliha Moutaharrik
IFIlaria Filippin
Ilaria Filippin
AFAnastasia Foppoli
Anastasia Foppoli
LPLuca Palugan
Luca Palugan
MCMatteo Cerea
Matteo Cerea
Despite poor absorption properties, delivery to the colon of bioactive compounds administered by the oral route has become a focus of pharmaceutical research over the last few decades. In particular, the high prevalence of Inflammatory Bowel Disease has driven interest because of the need for improved pharmacological treatments, which may provide high local drug concentrations and low systemic exposure. Colonic release has also been explored to deliver orally biologics having gut stability and permeability issues. For colon delivery, various technologies have been proposed, among which time-dependent systems rely on relatively constant small intestine transit time. Drug delivery platforms exploiting this physiological feature provide a lag time programmed to cover the entire small intestine transit and control the onset of release. Functional polymer coatings or capsule plugs are mainly used for this purpose, working through different mechanisms, such as swelling, dissolution/erosion, rupturing and/or increasing permeability, all activated by aqueous fluids. In addition, enteric coating is generally required to protect time-controlled formulations during their stay in the stomach and rule out the influence of variable gastric emptying. In this review, the rationale and main delivery technologies for oral colon delivery based on the time-dependent strategy are presented and discussed.

20 May 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Alice MelocchiAlice Melocchi
Alice Melocchi
MUMarco Uboldi
Marco Uboldi
BFBriatico-Vangosa Francesco
Briatico-Vangosa Francesco
Saliha MoutaharrikSaliha Moutaharrik
Saliha Moutaharrik
MCMatteo Cerea
Matteo Cerea
Andrea GazzanigaAndrea Gazzaniga
Andrea Gazzaniga
The pulsatile-release Chronotopic™ system was conceived of as a drug-containing core surrounded by a coat made of swellable/soluble hydrophilic polymers, the latter being able to provide a programmable lag phase prior to drug liberation. This system was also proposed in a colon-targeting configuration, entailing a gastroresistant film to prevent early interaction of the inner coat with gastric fluids and enabling the attainment of a lag phase matching the small intestinal transit time. Over the years, various multiple-step manufacturing processes have been tested for the fabrication of the Chronotopic™ system in both its configurations. This work focused on the evaluation of 3D printing by fused deposition modeling in view of its potential towards product personalization, on demand one-step manufacturing and efficient scale down of batches. The feasibility of each part of the Chronotopic™ system was independently investigated starting from in-house made filaments, characterizing the resulting specimens for physico-technological and performance characteristics. The printing parameters identified as suitable during the set-up phase were then used to fabricate prototypes either in a single step for the pulsatile configuration or following two different fabrication approaches for the colon-targeting one.